Mast cell activation syndrome

(Mast cell activation disorders, SAMA)

Relatively new entity (first published in 2007). Immune pathology in which mast cells  inappropriately and excessively release the chemical mediators contained in their granules [histamine, heparin, prostaglandins, Platelet Activating Factor, angiotensin-converting enzyme, leukotrienes, proteolytic enzymes, cytokines, TNF alpha]. This causes chronic and/or recurrent symptoms, including  anaphylactic shock or similar conditions. Unlike  mastocytosis, where patients have an increased number of mast cells, patients with SAMA have a normal number of these cells, but these are defined as "hyperreactive". 


The causes are:


The main symptoms can fluctuate in their type, severity and duration. Many manifestations and symptoms are the same as those of mastocytosis.


Common symptoms are:


Symptoms can be caused or aggravated by triggers, which vary widely and are specific.


Common triggering factors are:


Treatment: mainly symptomatic


Anesthetic implications:

increased risk of anaphylactic reaction; although no cases of anesthetic management have been described, it is sound to apply the same recommendations as in case of mastocytosis (see this term).


References :


Updated: September 2021